-
New Study of Medical Cannabis in Multiple Sclerosis Filed with FDA
MMJ Bioscience, which specializes in medical cannabis products, has filed a request with the U.S. Food and Drug Administration (FDA) to open Phase 2 clinical trials evaluating the company’s THC/CBD pharmaceutical compounds as possible treatments for symptoms of multiple sclerosis (MS).
THC refers to the tetrahydrocannabinol compound, part of the cannabis plant. CBD stands for cannabidiol, the compound that is thought to have the most healing potential. Read more here: MMJ Bioscience Files Request with FDA to Open Phase 2 Study of Medical Cannabis in Progressive MS
Have you ever tried medical cannabis to help with your symptoms? Would you recoommend it?
Sorry, there were no replies found.
Log in to reply.